Long-term safety and effectiveness of canakinumab in CAPS: results from the β-Confident Registry

Kuemmerle-Deschner JB, Ramos E, Engel K, et al.

RMD Open · 2021

Grade Bcohort

Key Findings

  • Real-world registry
  • 6-year safety and effectiveness data

Referenced in (1 disease)

ID: pmid-34001647PMID: 34001647